UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 23, 2014 1:00 P.M.
Form:
S-1
CIK:
0001321834
Company Name:
Akers Biosciences Inc
File Number:
333-190456